🔗 Share this article

An underground economy for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with numerous of members share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Professionals Express Concerns

However, physicians and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users administering products of unknown origin.

Several experts stated the demand for retatrutide could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach medicines, advertising, and consumer laws, risking fines, prosecution or imprisonment.

Platform Response and Material Elimination

Based on TikTok, the service has taken down violative content and prohibited related hashtags and query recommendations. The organization said it was committed to maintaining the service safe and investing in strengthening enforcement strategies.

Online Marketplace Operations

Research also discovered groups with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly brings up channels with numerous of members, filled with images of slimming results, positive reviews and detailed instructions for preparing or administering at home.

After moments of joining one group, a seller shared WhatsApp details, where most transactions occur. The seller provided an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, messages display black plastic parcels with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for Telegram said it regularly monitored dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are administering materials they can’t verify. Although the science behind this drug is sound, these digital products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has already seen individuals injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for human use,” they explained, noting that any product “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to potentially significant medical dangers”.